1. Home
  2. RECT vs PMN Comparison

RECT vs PMN Comparison

Compare RECT & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rectitude Holdings Ltd

RECT

Rectitude Holdings Ltd

N/A

Current Price

$1.67

Market Cap

26.1M

Sector

N/A

ML Signal

N/A

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$11.05

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RECT
PMN
Founded
1997
2004
Country
Singapore
Canada
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.1M
23.5M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
RECT
PMN
Price
$1.67
$11.05
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$72.67
AVG Volume (30 Days)
8.6K
16.9K
Earning Date
02-20-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.12
N/A
Revenue
$32,594,177.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.35
N/A
Revenue Growth
5.91
N/A
52 Week Low
$1.50
$6.27
52 Week High
$6.43
$39.75

Technical Indicators

Market Signals
Indicator
RECT
PMN
Relative Strength Index (RSI) 43.09 74.00
Support Level $1.58 $8.96
Resistance Level $1.90 $10.18
Average True Range (ATR) 0.10 0.65
MACD 0.01 0.12
Stochastic Oscillator 30.82 85.03

Price Performance

Historical Comparison
RECT
PMN

About RECT Rectitude Holdings Ltd

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: